![Contract drugmaker Catalent shows signs of recovery in Q1 revenue beat](/i/c/1c612366-6e05-8a2b-1d02-aadf04822408.webp)
Contract drugmaker Catalent shows signs of recovery in Q1 revenue beat
(Reuters) -Catalent beat Wall Street's estimates for first-quarter revenue on Wednesday, as the contract drug manufacturer showed signs of improvement
2023-11-15 21:56
![Catalent delays quarterly filing with SEC on $700 million impairment charge](/i/c/cdd553c0-f9c5-2876-14bd-4cbc7364226c.webp)
Catalent delays quarterly filing with SEC on $700 million impairment charge
Catalent will delay its quarterly filing with the U.S. securities regulator due to a goodwill impairment charge of
2023-11-14 22:57
![Catalent revenue falls, delays annual report](/i/c/3abdf1a4-7034-5597-c615-2eb8287ddae6.webp)
Catalent revenue falls, delays annual report
Catalent Inc reported a 17% fall in quarterly revenue on Tuesday, hurt by persistent production-related challenges at the
2023-08-29 19:27
![Exclusive-Catalent nears settlement with Elliott for board seats -sources](/i/c/8900f80d-0ed8-f226-60a1-d19d3d13a45b.webp)
Exclusive-Catalent nears settlement with Elliott for board seats -sources
By Svea Herbst-Bayliss and Maggie Fick Catalent Inc is close to reaching a settlement with Elliott Investment Management
2023-08-29 05:15
![China quietly recruits overseas chip talent as US tightens curbs](/i/c/508af4a0-fa89-f9aa-d044-f16f1b0a31c5.webp)
China quietly recruits overseas chip talent as US tightens curbs
By Julie Zhu, Fanny Potkin, Eduardo Baptista and Michael Martina HONG KONG/SINGAPORE/WASHINGTON For a decade until 2018, China
2023-08-24 09:48
![Catalent, facing pressure from Elliott, had other activists in stock](/i/c/7399be2c-c972-ace4-ce68-de90b6ec5511.webp)
Catalent, facing pressure from Elliott, had other activists in stock
By Svea Herbst-Bayliss NEW YORK Contract drugmaker Catalent, which is being pushed to make changes to its board
2023-08-15 06:49
![Activist investor Elliott takes big stake in drugmaker Catalent - WSJ](/i/c/174e22e7-5600-e764-cf12-dd712334dc28.webp)
Activist investor Elliott takes big stake in drugmaker Catalent - WSJ
Activist investor Elliott Investment has built a significant stake in Catalent and is pushing for a shake-up on
2023-07-20 07:48
![The Supreme Court's affirmative action ruling could hurt the job prospects for candidates of color](/i/c/8b5f5df6-3ca4-d09a-3d2c-b0d4f10109ba.webp)
The Supreme Court's affirmative action ruling could hurt the job prospects for candidates of color
The Supreme Court's landmark decision shooting down affirmative action could hurt the college-to-career pipeline many companies lean on to diversify their ranks.
2023-06-30 18:26
![Catalent reports bigger-than-expected loss on production challenges](/i/c/8383e2cb-4728-eab4-678c-60fb5d26a479.webp)
Catalent reports bigger-than-expected loss on production challenges
(Reuters) -Catalent Inc on Monday posted a bigger-than-expected loss for the third quarter, hurt by persistent production challenges at the
2023-06-12 19:18